Yitao M. Ou
280 Wai Huan Dong Road
Guangzhou, 510006, China
Guangzhou, 510006, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
A case of primary giant gastrointestinal stromal tumor of the liver
Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: October 16, 2024
Chlorquinaldol Alleviates Lung Fibrosis in Mice by Inhibiting Fibroblast Activation through Targeting Methionine Synthase Reductase.
Journal: ACS central science
Published: May 18, 2024
Discovery of a selective NLRP3-targeting compound with therapeutic activity in MSU-induced peritonitis and DSS-induced acute intestinal inflammation.
Journal: Cellular and molecular life sciences : CMLS
Published: April 27, 2023
Antagonizing interleukin-5 receptor ameliorates dextran sulfate sodium-induced experimental colitis in mice through reducing NLRP3 inflammasome activation.
Journal: European journal of pharmacology
Published: February 20, 2023
Artemisinin-derived artemisitene blocks ROS-mediated NLRP3 inflammasome and alleviates ulcerative colitis.
Journal: International immunopharmacology
Published: September 06, 2022
Discovery of a Novel Oral Proteasome Inhibitor to Block NLRP3 Inflammasome Activation with Anti-inflammation Activity.
Journal: Journal of medicinal chemistry
Published: September 05, 2022
Bortezomib inhibits NLRP3 inflammasome activation and NF-κB pathway to reduce psoriatic inflammation.
Journal: Biochemical pharmacology
Published: August 18, 2022
Seratrodast, a thromboxane A2 receptor antagonist, inhibits neuronal ferroptosis by promoting GPX4 expression and suppressing JNK phosphorylation.
Journal: Brain research
Published: April 01, 2022
Ciclopirox inhibits NLRP3 inflammasome activation via protecting mitochondria and ameliorates imiquimod-induced psoriatic inflammation in mice.
Journal: European journal of pharmacology
Published: March 21, 2022
Chlorquinaldol inhibits the activation of nucleotide-binding oligomerization domain-like receptor family pyrin domain-containing protein 3 inflammasome and ameliorates imiquimod-induced psoriasis-like dermatitis in mice.
Journal: Chemico-biological interactions
Published: March 01, 2022
Discovery of chalcone analogues as novel NLRP3 inflammasome inhibitors with potent anti-inflammation activities.
Journal: European journal of medicinal chemistry
Published: March 01, 2021
Tanshinones inhibit NLRP3 inflammasome activation by alleviating mitochondrial damage to protect against septic and gouty inflammation.
Journal: International immunopharmacology
Published: March 01, 2021
Last Updated: 09/26/2026